Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 129-133

  Valerón, Pilar F ^a   Chirino, Ricardo ^a   Fernandez, Leandro ^a   Torres, Santiago ^a   Navarro, Domingo ^a   Aguiar, José ^b   Cabrera, Juan J ^a   Diaz Chico, Bonifacio N ^a   Diaz Chico, Juan C ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b Hospital Nuestra Senora del Pino   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; BREAST NEOPLASMS; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0030030843     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960117)65:2<129::AID-IJC1>3.0.CO;2-0     Document Type: Article

References (23)

1. BERNS, E.M., KLIJN, J.G., VAN PUTTEN, W.L., VAN STAVEREN, I.L., PORTENGEN, H. and FOEKENS, J.A., c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res., 52, 1107-1113 (1992).
2. BORG, A., TANDON, A.K., SIGURDSSON, H., CLARK, G.M., FERNO, M., FUQUA, S.A.W., KILLANDER, D. and MCGUIRE, W.L., HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res., 50, 4332-4337 (1991).
3. CARNEY, W.P., HARMER, P.J., PETIT, D., RETOS, C., GREENE, R., ZABRECKY, J.R., MCKENZIE, S., HAYES, D., KUFE, D., DELELLIS, R., NABER, S and WOLFE, H., Detection and quantitation of the human neu oncoprotein. J. Tumor Marker Oncol., 6, 53-72 (1991).
4. CLARK, G.M., and MCGUIRE, W.L., Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res., 51, 944-948 (1991).
5. FRYE, R A., BENZ, C.C. and LIU, E., Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene, 4, 1153-1157 (1989).
6. GRAY, P.W. and GOEDDEL, D.V., Structure of the human immune interferon gene. Nature (Lond.), 298, 859-863 (1982).
7. GULLICK, W.J., LOVE, S.B., WRIGHT, C., BARNES, D.M., GUSTERSON, B., HARRIS, A.L. and ALTMAN, D.G., C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Brit. J. Cancer, 63, 434-438 (1991).
8. HYNES, N.E. and STERN, D.F., The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. biophys. Acta , 1198, 165-184 (1994).
9. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227, 680-685 (1971).
10. LIU, E., THOR, A., HE, M., BARCOS, M., LJUNG, B.M. and BENZ, C., Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene, 7, 1027-1032 (1992).
11. MCCANN, A., DERVAN, P.A., O'REGAN, M., CODD, M.B., GULLICK, W.J., TOBIN, B.M.J. and CARNEY, D.N., Prognostic significance of c-erbB-2 and estrogen-receptor status in human breast cancer. Cancer Res., 51, 3296-3303 (1991).
12. MCKENZIE, S.J., MARKS, P.J., LAM, T., MORGAN, J., PANICALI, D.L., TRIMPE, K.L. and CARNEY, W.P., Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene, 4, 543-548 (1989).
13. NEUBAUER, A., NEUBAUER, B., HE, M., EFFERT, P., IGLEHART, D., FRYE, R.A. and LIU, E., Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene, 7, 1019-1025 (1992).
14. 1 gene introduced into cultured mouse cells. Nucleic Acids Res., 10, 967-977 (1982).
15. PRESS, M.F., PIKE, M.C., CHAZIN, V.R., HUNG, G., UDOVE, J.A., MARKOWICZ, M., DANYLUK, J., GODOLPHIN, W., SLIWKOWSKI, M., AKITA, R., PATERSON, M.C. and SLAMON, D.J., HER-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of over-expression with increased risk of recurrent disease. Cancer Res., 53, 4960-4970 (1993).
16. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning, a laboratory manual, (2nd ed.), Cold Spring Harbor Laboratory, New York (1989)
17. SEMBA, K., KAMATA, N., TOYOSHIMA, K. and YAMAMOTO, T.A., V-erbB-related proto-oncogene, c-erb B-2, is distinct from the c-erb B-1/ epidermal-growth-factor-receptor gene and is amplified in a human salivary-gland adenocarcinoma. Proc. nat. Acad. Sci. (Wash.), 82, 6497-6501 (1985).
18. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A., and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
19. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
20. TANDON, A.K., CLARK, G.M., CHAMNESS, G.C., ULLRICH, A. and MCGUIRE, W.L., HER-2/neu oncogene protein and prognosis in breast cancer. J. clin. Oncol., 7, 1120-1128 (1989).
21. VAN DE VIJVER, M.J., PETERSE, J.L., MOOI, W.J., WISMAN, P., LOMANS, J., DALESIO, O. and NUSSE, R., Neu protein over-expression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage-II breast cancer. New Engl. J. Med., 319, 1239-1245 (1988)
22. YAMAMOTO, T., IKAWA, S., AKIYAMA, T., SEMBA, K., NOMURA, N., MIYAJIMA, N., SAITO, T. and TOYOSHIMA, K., Similarity of protein encoded by the human c-erb-B-2 gene to epidermal-growth-factor receptor. Nature (Lond.), 319, 230-234 (1986).
23. ZHOU, D.J., AHUJA, H. and CLINE, M.J., Proto-oncogen abnormalities in human breast cancer: c-erb-2 amplification does not correlate with recurrence of disease. Oncogene, 4, 105-108 (1989).